4th Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery

High Throughput Technology for Hit Generation

 Virtual Event    May 15-16, 2024

Programme



16:00

Opening & introduction

Dr Allen ANNIS
AILERON THERAPEUTICS, Cambridge, United States
Dr Didier ROCHE
EDELRIS, Lyon, France
16:05

Start of session

Session 1
Session 1
16:05
PL01 - Simplifying Affinity MS: A One-Step Approach
Prof. Ronald QUINN
GRIFFITH UNIVERSITY, Brisbane, Australia
16:50
PL02 - An Affinity for Automation
Mr Marcel LACHENMANN
MESTRELAB RESEARCH, Newton, United States
17:05
Break
17:15
PL03 - Nanoscale Synthesis of Cyclic Peptide Libraries and AS-MS Screening
Prof. Christian HEINIS
ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL), Lausanne, Switzerland
17:50
PL04 - Versatile Externalized ASMS Platforms Applied in Lead ID
Dr Hans-Peter BIEMANN
SANOFI US, Cambridge, United States
18:25
Round table discussion & closing remarks
16:00

Opening remarks Day 2

Dr Joseph GAULT
ASTRAZENECA, Cambridge, United Kingdom
16:05

Start of session

Session 2
Session 2
16:05
PL05 - Integration of Massive Metabolite Profiling Data of Natural Extracts in Bioactivity Screening Campaigns for Bioactive Hits Prediction and Efficient Prioritization
Prof. Jean-Luc WOLFENDER
UNIVERSITY OF GENEVA, Geneva, Switzerland
16:40
PL06 - EDEN to Take on New Challenges in Drug Discovery
Dr Charlotte HUROT
EDELRIS, Lyon, France
17:15
Break
17:25
PL07 - An E3 Handle and a Chemical Probe for GID4 via ASMS Hit ID
Dr Dafydd OWEN
PFIZER, Cambridge, United States
18:00
Round table discussion & closing remarks